vTv Therapeutics registers 15.9M Class A shares for potential resale

Published 1 month ago Positive
vTv Therapeutics registers 15.9M Class A shares for potential resale
Auto
* vTv Therapeutics (VTV [https://seekingalpha.com/symbol/VTV]) registered 15.88M Class A common shares for resale by selling stockholders.
* Includes 2.13M outstanding shares, plus shares issuable from warrants: 8.47M shares via pre-funded warrants and 5.27M shares via common warrants.
* Shares originated from letter agreements, Class B to Class A conversions, and private placements in February 2024 and September 2025.
* Warrants were also issued through these agreements and private placements.
* vTv will not receive proceeds from resale by Selling Stockholders.
* Source: SEC filing [https://seekingalpha.com/filing/10496302]

MORE ON VTV THERAPEUTICS

* vTv Therapeutics announces $80M PIPE financing; shares up 14% [https://seekingalpha.com/news/4491147-vtv-therapeutics-announces-80m-pipe-financing-shares-up-14]
* Seeking Alpha’s Quant Rating on vTv Therapeutics [https://seekingalpha.com/symbol/VTVT/ratings/quant-ratings]
* Historical earnings data for vTv Therapeutics [https://seekingalpha.com/symbol/VTVT/earnings]
* Financial information for vTv Therapeutics [https://seekingalpha.com/symbol/VTVT/income-statement]